Yield10 Bioscience Inc (YTEN) Gets a Buy Rating from Maxim Group

By Ryan Adsit

In a report released today, James Jang from Maxim Group maintained a Buy rating on Yield10 Bioscience Inc (YTENResearch Report), with a price target of $4.50. The company’s shares closed yesterday at $1.05.

Jang said:

“Yesterday, post-close, Yield10 reported 1Q19 results that were inline with expectations.”

According to TipRanks.com, Jang is a 3-star analyst with an average return of 2.0% and a 37.7% success rate. Jang covers the Services sector, focusing on stocks such as Sino-Global Shipping America, Eagle Bulk Shipping Inc, and Nordic American Tanker.

Currently, the analyst consensus on Yield10 Bioscience Inc is a Moderate Buy with an average price target of $4.50, a 328.6% upside from current levels. In a report released today, National Securities Corp also reiterated a Buy rating on the stock.

See today’s analyst top recommended stocks >>

Based on Yield10 Bioscience Inc’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $1.86 million. In comparison, last year the company had a GAAP net loss of $2.29 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.